BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3875968)

  • 21. Calcium-dependent and calcium-independent signals in the conglutinin-binding assay (KgBa) for immune complexes. Influence of anti-collagen-antibodies.
    Holmskov U; Haas H; Teisner B; Andersen O; Jensenius JC
    J Immunol Methods; 1992 Apr; 148(1-2):225-32. PubMed ID: 1564328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. C1q-bearing immune complexes detected by a monoclonal antibody to human C1q in rheumatoid arthritis sera and synovial fluids.
    Antes U; Heinz HP; Schultz D; Brackertz D; Loos M
    Rheumatol Int; 1991; 10(6):245-50. PubMed ID: 2041983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An efficient one-step method for isolating immune complexes from whole serum using a monoclonal anti-C3g affinity immunosorbent.
    Samuel DJ; Amlot PL; Shepherd P; Lachmann PJ
    Clin Exp Immunol; 1986 Aug; 65(2):458-64. PubMed ID: 3491710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation of C3d fixing circulating immune complexes with disease activity and clinical parameters in patients with systemic lupus erythematosus.
    Sekita K; Doi T; Muso E; Yoshida H; Kanatsu K; Hamashima Y
    Clin Exp Immunol; 1984 Mar; 55(3):487-94. PubMed ID: 6608422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of the alternative complement pathway by the immune precipitate formed with F(ab')2 fragment of human IgG antibody.
    Akagaki Y; Inai S
    Mol Immunol; 1983 Nov; 20(11):1221-6. PubMed ID: 6419059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complement activating properties of complexes containing rheumatoid factor in synovial fluids and sera from patients with rheumatoid arthritis.
    Elson CJ; Carter SD; Cottrell BJ; Scott DG; Bacon PA; Wallington TB
    Clin Exp Immunol; 1985 Feb; 59(2):285-92. PubMed ID: 3978872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of protein A and concanavalin A to examine the possible role of the carbohydrate of IgG in the binding of Clq.
    van Schravendijk MR; Dwek RA
    Mol Immunol; 1981 Dec; 18(12):1079-85. PubMed ID: 6977701
    [No Abstract]   [Full Text] [Related]  

  • 28. Hepatitis B surface antigen containing immune complexes occur in seronegative hepatocellular carcinoma patients.
    Brown SE; Howard CR; Steward MW; Ajdukiewicz AB; Whittle HC
    Clin Exp Immunol; 1984 Feb; 55(2):355-9. PubMed ID: 6199140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence for the presence of autoantibodies to the collagen-like portion of C1q in systemic lupus erythematosus.
    Antes U; Heinz HP; Loos M
    Arthritis Rheum; 1988 Apr; 31(4):457-64. PubMed ID: 3258749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibody to a cryptic, solid phase C1Q antigen in membranoproliferative nephritis.
    Strife CF; Leahy AE; West CD
    Kidney Int; 1989 Mar; 35(3):836-42. PubMed ID: 2785226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum and plasma fibronectin binds to complement reacted immune complexes primarily via Clq.
    Baatrup G; Svehag SE
    Scand J Immunol; 1986 Nov; 24(5):583-90. PubMed ID: 3097811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative study of circulating immune complexes quantity detection by three assays--CIF-ELISA, C1q-ELISA and anti-C3 ELISA.
    Stanilova SA; Slavov ES
    J Immunol Methods; 2001 Jul; 253(1-2):13-21. PubMed ID: 11384665
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-C1q column: ligand specific purification of immune complexes from human serum or plasma. Analysis of the interaction between C1q and immune complexes.
    Kilgallon W; Amlot PL; Williams BD
    Clin Exp Immunol; 1982 Jun; 48(3):705-14. PubMed ID: 6811171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Common epitopes in Clq and collagen type II.
    Heinz HP; Rubin K; Laurell AB; Loos M
    Mol Immunol; 1989 Feb; 26(2):163-9. PubMed ID: 2465489
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased plasma levels of IgA-IgG immune complexes and anti-F(ab')2 antibodies in patients with type 2 (non insulin-dependent) diabetes mellitus and microangiopathy.
    Casiglia D; Giardina E; Scarantino G; Triolo G
    Diabetes Res; 1990 Dec; 15(4):195-200. PubMed ID: 2132409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immune complexes in coccidioidomycosis. Correlation with disease involvement.
    Cox RA; Pope RM; Stevens DA
    Am Rev Respir Dis; 1982 Sep; 126(3):439-43. PubMed ID: 6982011
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Raji, conglutinin, and anti-C3 assays for the detection of complement-fixing immune complexes.
    Theofilopoulos AN
    Methods Enzymol; 1981; 74 Pt C():511-30. PubMed ID: 7321895
    [No Abstract]   [Full Text] [Related]  

  • 38. Binding of complement components C1q, C3, C4 and C5 to a model immune complex in ELISA.
    Larsson A; Sjöquist J
    J Immunol Methods; 1989 Apr; 119(1):103-9. PubMed ID: 2785142
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stimulation of complement amplification by F(ab')(2)-containing immune complexes and naturally occurring anti-hinge antibodies, possible role in systemic inflammation.
    Lutz HU; Fumia S
    Autoimmun Rev; 2008 Jun; 7(6):508-13. PubMed ID: 18558371
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interference by rheumatoid factor and C1q in the detection of IgG complexes: studies of model systems by ELISA.
    Wager O; Lindstrøm P
    Scand J Immunol; 1982 Mar; 15(3):319-28. PubMed ID: 6979777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.